Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 10,851–10,875 of 27,380 studies, newest first · page 435 of 1096.

December 2020 25

  1. 2020-12-18

    An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

    ✓ Peer-reviewed TREM2 and immune genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The NTK contains promising markers that improve the pathophysiological characterization of AD.

  2. 2020-12-18

    Electronic Cognitive Screen Technology for Screening Older Adults With Dementia and Mild Cognitive Impairment in a Community Setting: Development and Validation Study

    ✓ Peer-reviewed Cognitive tests and assessment Journal of medical Internet research

    Key finding: Previous studies have shown that the diagnostic performance of digital cognitive tests is comparable with that of conventional paper-and-pencil tests. +2 more findings

  3. 2020-12-18

    Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review

    ✓ Peer-reviewed Inflammation and the immune system Molecules (Basel, Switzerland)

    Key finding: Alzheimer's disease (AD) is closely associated with aging and is defined by increasing memory loss and severe dementia. +2 more findings

  4. 2020-12-17

    Can Anti-β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?

    ✓ Peer-reviewed Treatments Neurology. Genetics

    Key finding: Two long-term preventive studies (Dominantly Inherited Alzheimer Network Trials Unit Adaptive Prevention Trial [DIAN-TU-APT] and Alzheimer Preventive Initiative-ADAD) were set up to evaluate the efficacy of monoclonal anti-Aβ antibodies (solanezumab, gantenerumab, and crenezumab) in carriers of ADAD, but the results of the DIAN-TU-APT study have shown that neither solanezumab nor gantenerumab slowed cognitive decline in 144 subjects with ADAD followed for 4 years, despite one of the drugs (gantenerumab) significantly affected biomarkers relevant to their intended mechanism of action. +2 more findings

  5. 2020-12-17

    Orally Administered Benzofuran Derivative Disaggregated Aβ Plaques and Oligomers in the Brain of 5XFAD Alzheimer Transgenic Mouse

    ✓ Peer-reviewed Drug development ACS chemical neuroscience

    Key finding: Aβ abnormally accumulates in the brain and induces neuronal damages and symptoms of AD such as cognitive impairment and memory loss. +3 more findings

  6. 2020-12-16

    Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study

    ✓ Peer-reviewed Risk factors NeuroImage. Clinical

    Key finding: Compared to healthy controls, patients with FTD showed glucose hypometabolism in bilateral frontal and temporal brain areas whereas cognition was only associated with deteriorated glucose metabolism in the left temporal lobe. +2 more findings

  7. 2020-12-15

    Fibrinogen isoforms as potential blood-based biomarkers of Alzheimer's disease using a proteomics approach

    ✓ Peer-reviewed Biomarkers The International journal of neuroscience

    Key finding: Mass spectrometry (MS)-based protein identification via MALDI ToF/ToF showed that fibrinogen-β-chain (spot 64) and fibrinogen-γ-chain (spot 91) with differential expression ratio >1.5 were significantly upregulated (p < 0.05) in AD patients when compared to non-AD individuals. +4 more findings

  8. 2020-12-15

    Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials

    ✓ Peer-reviewed Drug development Dementia and geriatric cognitive disorders

    Key finding: Alzheimer disease (AD) is a chronic neurodegenerative disorder with complex pathophysiology that affects over 50 million people worldwide. +3 more findings

  9. 2020-12-14
  10. 2020-12-14

    Deep Learning-Based Screening Test for Cognitive Impairment Using Basic Blood Test Data for Health Examination

    ✓ Peer-reviewed Biomarkers Frontiers in neurology

    Key finding: There were significant positive correlations between the predicted MMSE scores and ground truth scores in the Patient and Healthy groups (r = 0.66, p < 0.001). +4 more findings

  11. 2020-12-14

    How to measure the effects and potential adverse events of palliative sedation? An integrative review

    ✓ Peer-reviewed End-of-life care Palliative medicine

    Key finding: There are palliative care validated instruments to assess the sedation effect but this review shows the need for a more standardized approach when assessing it.

  12. 2020-12-14

    Exercise interventions preserve hippocampal volume: A meta-analysis

    ✓ Peer-reviewed Prevention trials Hippocampus

    Key finding: Exercise may be effective at increasing and preserving hippocampal volume, potentially serving as a treatment for conditions associated with hippocampal atrophy (e.g., dementia). +3 more findings

  13. 2020-12-14

    Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

    ✓ Peer-reviewed Inflammation and the immune system Nature reviews. Neurology

    Key finding: According to the prevailing amyloid cascade hypothesis, amyloid-β (Aβ) deposition in the brain is the initiating event in AD, although evidence is accumulating that this hypothesis is insufficient to explain many aspects of AD pathogenesis. +3 more findings

  14. 2020-12-14

    Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown

    ✓ Peer-reviewed Digital health tools Frontiers in psychiatry

    Key finding: All groups showed a worsening of cognitive (39.6%), pre-existing (37.5%), and new (26%) behavioral symptoms, and motor symptoms (35.4%) during the COVID-19 lockdown, resulting in an increased caregiver burden in 26% of cases. +4 more findings

  15. 2020-12-14

    Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia

    ✓ Peer-reviewed Biomarkers European journal of neurology

    Key finding: These results suggest that emerging biomarkers in conjunction with core AD markers improve diagnosis of AD, are associated with the conversion from MCI into AD, and predict a faster progression of dementia. +2 more findings

  16. 2020-12-13

    REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment

    ✓ Peer-reviewed Disease mechanisms International journal of molecular sciences

    Key finding: Previous findings suggested that a protein regulated in development and DNA damage response 1 (REDD1), a stress-coping regulator, is an Aβ-responsive gene involved in Aβ cytotoxicity. +4 more findings

  17. 2020-12-12

    Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice

    ✓ Peer-reviewed TREM2 and immune genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Herein, we demonstrate that endogenous Tyrobp transcription is specifically increased in recruited microglia. +3 more findings

  18. 2020-12-11

    Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid

    ✓ Peer-reviewed End-of-life care Journal of the American Medical Directors Association

    Key finding: Mortality of the residents living in NHs with COVID-19 was almost 45%. +4 more findings

  19. 2020-12-10

    Successful Discharge to Community Gap of FFS Medicare Beneficiaries With and Without ADRD Narrowed

    ✓ Peer-reviewed Costs and economics Journal of the American Geriatrics Society

    Key finding: Successful discharge of beneficiaries with ADRD increased from 43.4% in 2007 to 53.9% in 2015 (average annual percent change (AAPC) = 2.1 (95% CI = 2.0-2.2)); those without ADRD also increased (from 59.1% to 63.6%, AAPC = 0.9 (95% CI = 0.7-1.1)) but not as fast as those with ADRD (P < .01). +3 more findings

  20. 2020-12-10

    Revisiting the Role of Physicians in Assisted Living and Residential Care Settings

    ✓ Peer-reviewed Health systems and care delivery Gerontology & geriatric medicine

    Key finding: This change increases physicians' need for information about assisted living and residential care (AL/RC) settings, which provide supportive care and housing to older adults. +4 more findings

  21. 2020-12-10

    The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in immunology

    Key finding: During dysbiosis, these pathways are dysregulated and associated with altered permeability of the blood-brain barrier (BBB) and neuroinflammation. +1 more finding

  22. 2020-12-10

    Current Clinical Applications of In Vivo Gene Therapy with AAVs

    ✓ Peer-reviewed Brain scans and imaging Molecular therapy : the journal of the American Society of Gene Therapy

    Key finding: This review is limited to gene therapy using adeno-associated virus (AAV) because the gene delivered by this vector does not integrate into the patient genome and has a low immunogenicity. +4 more findings

  23. 2020-12-09

    Palliative and end of life care for people with advanced dementia

    ✓ Peer-reviewed End-of-life care Nursing older people

    Key finding: Despite growing understanding in recent years of the biological, psychological, social, environmental and spiritual aspects of dementia, people with advanced dementia continue to experience inequalities in accessing healthcare capable of improving their lives. +4 more findings

  24. 2020-12-08

    Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Neurobiology of aging

    Key finding: Ever-mounting evidence suggests that UPS deficits contribute to p-tau accumulation.

  25. 2020-12-08

    Engaging persons with dementia in advance care planning: Challenges and opportunities

    ✓ Peer-reviewed End-of-life care Dementia (London, England)

    Key finding: Although individually focused models of ACP engagement hold promise for those persons with dementia ready to engage in future planning, our findings suggest that early engagement of families in the reflective process may go a long way in supporting ACP activation. +1 more finding

Browse the library by subject, with the full score breakdown →